Center For Neurologic Spec is categorized under Neurologists in Marlton, NJ and active since 2008.
Center For Neurologic Spec was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 5222920 by the NAICS.
If you are seeking more information, feel free to contact Charito Mabanta, Manager at the company’s single location by writing to 12000 Lincoln Drive West # 204, Marlton, New Jersey NJ 08053 or by phoning (856) 988-3444. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Center For Neurologic Spec |
| Contact Person: | Charito Mabanta, Manager |
| Address: | 12000 Lincoln Drive West # 204, Marlton, New Jersey 08053 |
| Phone Number: | (856) 988-3444 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Neurologists |
| SIC Code: | 8011 |
| NAICS Code: | 5222920 |
| Share This Business: |
Center For Neurologic Spec was started in 2008 to provide professional Neurologists under the SIC code 8011 and NAICS code 5222920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Charito Mabanta, Manager for inquiries that concern Center For Neurologic Spec by calling the company number (856) 988-3444, as your correspondence is most welcome. Additionally, the physical location of the single location of Center For Neurologic Spec can be found at the coordinates 39.902658,-74.935274 as well as the street address 12000 Lincoln Drive West # 204 in Marlton, New Jersey 08053.
For its online presence, you may visit Center For Neurologic Spec’s website at and engage with its social media outlets through on Twitter and on Facebook.